Kai Cui
7Patents
2h-index
53Co-inventors
50Inventor score
Filing activity: Nov 10, 2009 → Jan 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10710980B2 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10947218B2 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10933064B2 | Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts | Chemistry; Metallurgy | 1 | Active |
| US9968717B2 | Scaffold with drug coating for treating restenosis and preparation method thereof | Human Necessities | 0 | Active |
| US12084470B2 | Method for preparing bisphenol phosphate hydroxyl aluminum salt nucleating agent | Chemistry; Metallurgy | 0 | Active |
| US11654144B2 | Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts | Chemistry; Metallurgy | 0 | Active |
| US8664182B2 | Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.